Investigator-led trial of Lilly’s merestinib in solid tumours terminated

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 29, 2024 at 11:42 AM.

  1. #1 cafead, Apr 29, 2024 at 11:42 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,305
    Likes Received:
    3
    via Eli Lilly’s merestinib has seen its Phase Transition Success Rate (PTSR) drop after an investigator-led Phase II trial of the candidate in solid tumors was terminated.

    article source
     
    Quote

Reply to Thread